Cargando…
What is the optimum time to start antiretroviral therapy in people with HIV and tuberculosis coinfection? A systematic review and meta‐analysis
BACKGROUND: HIV and tuberculosis are frequently diagnosed concurrently. In March 2021, World Health Organization recommended that antiretroviral therapy (ART) should be started within two weeks of tuberculosis treatment start, at any CD4 count. We assessed whether earlier ART improved outcomes in pe...
Autores principales: | Burke, Rachael M, Rickman, Hannah M, Singh, Vindi, Corbett, Elizabeth L, Ayles, Helen, Jahn, Andreas, Hosseinipour, Mina C, Wilkinson, Robert J, MacPherson, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294654/ https://www.ncbi.nlm.nih.gov/pubmed/34289243 http://dx.doi.org/10.1002/jia2.25772 |
Ejemplares similares
-
Who Starts? Factors Associated with Starting Antiretroviral Therapy among Eligible Patients in Two, Public HIV Clinics in Lilongwe, Malawi
por: Feldacker, Caryl, et al.
Publicado: (2012) -
Accuracy of upper respiratory tract samples to diagnose Mycobacterium tuberculosis: a systematic review and meta-analysis
por: Savage, Helen R, et al.
Publicado: (2023) -
Community-based active case-finding interventions for tuberculosis: a systematic review
por: Burke, Rachael M, et al.
Publicado: (2021) -
Africa faces difficult choices in responding to COVID-19
por: Divala, Titus, et al.
Publicado: (2020) -
Know your tuberculosis epidemic–Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?
por: Rickman, Hannah M., et al.
Publicado: (2022)